Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens

QJM: An International Journal of Medicine

Volumn 103, Issue 11, 2010, Pages 847-863

  Sukocheva, O A ^a   Marmion, B P ^a   Storm, P A ^a   Lockhart, M ^b   Turra, M ^c   Graves, S ^b  

^a HANSON INSTITUTE   (Australia)

^b Australian Rickettsial Reference Laboratory   (Australia)

^c SA Pathology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; COXIELLA BURNETII ANTIGEN; INTERLEUKIN 10; Q FEVER VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BACTERIAL CELL; BACTERIAL GENOME; CASE STUDY; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; COXIELLA BURNETII; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; GENE SEQUENCE; GUINEA PIG; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTION; LABORATORY TEST; LIVER CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; Q FEVER; Q FEVER FATIGUE SYNDROME; SCID MOUSE; SKIN; SPLEEN CELL;

EID: 78649361502     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq113     Document Type: Article

References (35)

1. Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T. Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun 1996; 64:796-809.
2. Romano PS, Gutterez MG, Beron W, Rabinovitch M, Colomb MI. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host. Cellular Microbiol 2007; 9:891-909.
3. Zamboni DS, McGrath S, Rabinovitch M, Roy CR. Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophilia Dot/1 cm system. Mol Microbiol 2003; 49:11965-76.
4. Marmion BP, Sukocheva O, Storm PA, Lockhart M, Turra M, Kok T, et al. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host-implications for post Q fever infection fatigue syndrome and other chronic sequelae. QJM 2009; 102:673-84.
5. Ayres JG, Flint N, Smith EG, Tunnicliffe WS, Fletcher TJ, Hammon K, et al. Post infection fatigue syndrome following acute Q fever; follow-up study of patients involved in the 1989 outbreak in the West Midlands. QJM 1998; 91:105-23.
6. Marmion BP, Storm PA, Ayres JG, Semendric L, Matthews L, Winslow W, et al. Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 2005; 98:7-20.
7. Wildman MJ, Smith EG, Groves J, Beattie JM, Caul EO, Ayres JG. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. QJM 2002; 95:527-38.
8. Wessely S. Chronic fatigue: symptoms and syndrome. Ann Intern Med 2001; 134(9 Pt 2):838-43.
9. Shain KH, Landowski TH, Dalton WS. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines. J Immunol 2002; 168:2544-53.
10. Westphal O, Jann K. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Meth Carbohydr Chem 1965; 5:83-91.
11. Baiocchi RA, Caligiuri MA. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1994; 91:5577-81.
12. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 2007; 75:3245-55.
13. Leslie RGQ, Coupland K. The ingestion and degradation of soluble immune complexes by guinea-pig macrophages and neutrophils. Immunology 1985; 54:811-19.
14. Turra M, Chang G, Whybrow D, Higgins G, Qiao M. Diagnosis of acute Q fever by PCR on sera during a recent outbreak in rural south Australia. Ann NY Acad Sci 2006; 1078:566-9.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339:237-8.
16. Waag DM, Williams JC. Immune modulation by Coxiella burnetii: characterisation of a Phase I immunosuppressive complex differentially expressed among strains. Immunopharmacol Immunotoxicol 1988; 10:231-60.
17. Kraal G, Mebius R. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol 2006; 250:175-215.
18. Meghari S, Bechah Y, Capo C, Lepidi H, Raoult D, Murray PJ, et al. Persistent Coxiella b. infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis. PLoS Pathog 2008; 4:e23.
19. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-30.
20. Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, et al. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol 1984; 132:1804-8.
21. Lapidot T, Fajerman Y, Kollet O. Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human haematopoiesis. J Mol Med 1997; 75:664-73.
22. Blondiau C, Lagadec P, Lejeune P, Onier N, Cavaillon JM, Jeannin JF. Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiology 1994; 190:243-54.
23. Honstettre A, Ghigo E, Moynault A, Capo C, Toman R, Akira S, et al. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J Immunol 2004; 172:3695-703.
24. Theilgaard-Mönch K, Porse BT, Borregaard N. System biology of neutrophil differentiation and immune response. Curr Opin Immunol 2006; 18:54-60.
25. Marmion BP, Shannon M, Maddocks I, Storm PA, Pentilla IA. Protracted debility and fatigue after Q fever. Lancet 1996; 347:977-8.
26. Harris RJ, Storm PA, Lloyd A, Arens M, Marmion BP. Long term persistence of Coxiella b. in the host after primary Q fever. Epidemiol Infect 2000; 124:543-9.
27. Pentilla IA, Harris RJ, Storm PA, Haynes D, Worswick DA, Marmion BP. Cytokine dysregulation in the post Q fever fatigue syndrome. QJM 1998; 91:549-66.
28. Helbig KJ, Heatley SL, Harris RJ, Mullinghan PG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post Q fever fatigue syndrome. Genes and Immun 2003; 4:82-5.
29. Syrucek L, Sobeslavsky O, Gutvirth I. Isolation of Coxiella burnetii from human placentas. J Hyg Epidemiol Microbiol Immunol 1958; 2:29-35.
30. Abinanti FR. A study of the pathogenesis of Rickettsia burnetii infection in pregnant animals and of the immune response to Q fever infection. Dissertation. Cambridge, 1957.
31. Helbig K, Harris RJ, Ayres J, Dunckley H, Lloyd A, Robson J, et al. Immune response genes in the post Q fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever. QJM 2005; 98:565-74.
32. Kazar J. Coxiella burnetii infection. Ann NY Acad Sci 2005; 1063:105-14.
33. Baatout S. Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol 1996; 73:157-62.
34. Zhang L, Goudh J, Christmas D, Mattey D, Richards S, Main J, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol 2010; 63:156-64.
35. Fluge O, Mella O. Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurol 2009; 9:28.